Dr. Reddy's Laboratories to acquire branded generics business in India

Dr. Reddy's Laboratories will acquire select divisions of Wockhardt Limited's branded generics business in India, Nepal, Sri Lanka, Bhutan and Maldives.

Dr. Reddy's will acquire 62 brands across an array of specialties including neurology, dermatology, gastroenterology and pain management. The company will acquire all assets, including the sales and marketing teams and a manufacturing plant. Dr. Reddy's expects the transaction to close in the first quarter of the 2020 fiscal year.

More articles on surgery centers:
Wisconsin health system to open ASC — 3 insights
New York hospital opens pediatric surgery center, part of $120M investment
Iowa hospital opens $8.4M surgery center — 3 insights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers